| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Sylvie Tordjman | Q98512945 |
| P2093 | author name string | David Cohen | |
| Eric Bellissant | |||
| Guillaume Bronsard | |||
| Michel Botbol | |||
| George M Anderson | |||
| Solenn Kermarrec | |||
| Imen Najjar | |||
| Olivier Schischmanoff | |||
| Nemat Jaafari | |||
| Claire Fougerou | |||
| Julie Vernay-Leconte | |||
| Marianne Barburoth | |||
| Enas Lagdas | |||
| Rémi Fagard | |||
| Sophie Ribardiere | |||
| P2860 | cites work | Mutation screening of melatonin-related genes in patients with autism spectrum disorders | Q21202036 |
| Crystal structure and functional mapping of human ASMT, the last enzyme of the melatonin synthesis pathway | Q24292879 | ||
| Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis | Q24594076 | ||
| International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors | Q24623433 | ||
| Newborn infants detect the beat in music | Q24645247 | ||
| Abnormal melatonin synthesis in autism spectrum disorders | Q24652560 | ||
| Foundations for a new science of learning | Q24657078 | ||
| Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers | Q24795063 | ||
| Is ASMT a susceptibility gene for autism spectrum disorders? A replication study in European populations | Q28254534 | ||
| A circadian clock entrained by melatonin is ticking in the rat fetal adrenal | Q28568085 | ||
| Melatonin affects the temporal organization of the song of the zebra finch | Q45299460 | ||
| Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis | Q45375790 | ||
| Light-at-night-induced circadian disruption, cancer and aging | Q45817978 | ||
| Oxidative stress after sulfur mustard intoxication and its reduction by melatonin: efficacy of antioxidant therapy during serious intoxication. | Q45907352 | ||
| The tick-tock of language: is language processing sensitive to circadian rhythmicity and elevated sleep pressure? | Q45918046 | ||
| Endogenous melatonin provides an effective circadian message to both the suprachiasmatic nuclei and the pars tuberalis of the rat. | Q46193443 | ||
| Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes. | Q46459035 | ||
| Melatonin is able to prevent the liver of old castrated female rats from oxidative and pro-inflammatory damage | Q46523902 | ||
| Melatonin as a local regulator of human placental function | Q46692866 | ||
| A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities | Q46851680 | ||
| Light-induced melatonin suppression in humans with polychromatic and monochromatic light | Q46853731 | ||
| Behavioral manifestations of autism in the first year of life | Q47620861 | ||
| Melatonin: helping to MEND impaired sleep | Q48193622 | ||
| Sleep-wake characterization of double MT₁/MT₂ receptor knockout mice and comparison with MT₁ and MT₂ receptor knockout mice | Q48199618 | ||
| Exploring motor system contributions to the perception of social information: Evidence from EEG activity in the mu/alpha frequency range | Q48228121 | ||
| CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder? | Q48232008 | ||
| Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial | Q48243417 | ||
| Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome | Q48260113 | ||
| Effects of melatonin should be studied separately in each neurodevelopmental disorder and with specific sleep diagnoses | Q48268054 | ||
| Meta-analysing the effectiveness of melatonin for sleep-disturbed individuals with autism spectrum conditions: should Rett syndrome be included? | Q48288602 | ||
| Prolonged-release melatonin for children with neurodevelopmental disorders | Q48294909 | ||
| Oxytocin administration to parent enhances infant physiological and behavioral readiness for social engagement | Q48440643 | ||
| Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. | Q48492643 | ||
| Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study | Q48704147 | ||
| Effect of melatonin on sleep-wake rhythm: the sleep diary of an autistic male | Q48704186 | ||
| Parental report of sleep problems in children with autism | Q48721115 | ||
| Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism | Q44226251 | ||
| Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder | Q44476522 | ||
| Prophylactic treatment with melatonin after status epilepticus: effects on epileptogenesis, neuronal damage, and behavioral changes in a kainate model of temporal lobe epilepsy | Q44517611 | ||
| Sleep problems in children with mental handicap | Q45054456 | ||
| 'A child with severe night terrors and sleep-walking responds to melatonin therapy'. | Q45148578 | ||
| Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. | Q45225955 | ||
| Experimental evidence for synchronization to a musical beat in a nonhuman animal | Q29618656 | ||
| Social interaction shapes babbling: testing parallels between birdsong and speech | Q30011090 | ||
| Measuring progress in children with autism spectrum disorder who have cochlear implants. | Q30341551 | ||
| Do parentese prosody and fathers' involvement in interacting facilitate social interaction in infants who later develop autism? | Q30454840 | ||
| Do parents recognize autistic deviant behavior long before diagnosis? Taking into account interaction using computational methods | Q30474587 | ||
| Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. | Q30484771 | ||
| Tissue-specific abolition of Per1 expression in the pars tuberalis by pinealectomy in the Syrian hamster. | Q32106539 | ||
| Disorganized rhythm and synchrony: early signs of autism and Rett syndrome | Q33223913 | ||
| Early language acquisition: cracking the speech code | Q33268733 | ||
| Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population | Q33640009 | ||
| Melatonin treatment of non-epileptic myoclonus in children | Q33651060 | ||
| Inter-brain synchronization during social interaction | Q33680796 | ||
| Melatonin treatment of sleep-wake cycle disorders in children and adolescents | Q33716209 | ||
| Melatonin in children with autistic spectrum disorders: recent and practical data | Q33832237 | ||
| Sleep patterns of children with pervasive developmental disorders | Q33947349 | ||
| Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors | Q33948059 | ||
| Melatonin for insomnia in children with autism spectrum disorders | Q34009306 | ||
| Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. | Q34022705 | ||
| Infant intersubjectivity: research, theory, and clinical applications | Q34155460 | ||
| Melatonin in autism spectrum disorders: a systematic review and meta-analysis. | Q34180346 | ||
| Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands | Q34262263 | ||
| The nuclear receptor REV-ERBα is required for the daily balance of carbohydrate and lipid metabolism | Q34273148 | ||
| Human aging and melatonin. Clinical relevance. | Q34280211 | ||
| Treatment outcomes in REM sleep behavior disorder. | Q34324499 | ||
| Melatonin protects against apoptosis-inducing factor (AIF)-dependent cell death during acetaminophen-induced acute liver failure | Q34525832 | ||
| An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. | Q34555558 | ||
| Arylalkylamine N-acetyltransferase: "the Timezyme". | Q34573239 | ||
| Social timing, clock genes and autism: a new hypothesis | Q34631344 | ||
| Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes | Q34634252 | ||
| Organisation of the circadian system in melatonin-proficient C3H and melatonin-deficient C57BL mice: a comparative investigation | Q34732778 | ||
| The chronobiotic properties of melatonin | Q34732782 | ||
| Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis | Q34976753 | ||
| Melatonin in treatment of chronic sleep disorders in adults with autism: a retrospective study | Q34981745 | ||
| Melatonin: a clock-output, a clock-input | Q35080104 | ||
| Sleep disorder in Rett syndrome and melatonin treatment | Q48736466 | ||
| Sleep problems in autism: prevalence, cause, and intervention | Q48770519 | ||
| An investigation into sleep characteristics of children with autism and Asperger's Disorder. | Q48772674 | ||
| What is melatonin? Is it a useful treatment for sleep problems in autism? | Q48789268 | ||
| Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment | Q48801982 | ||
| The sleep/wake rhythm in children with autism | Q48810591 | ||
| The treatment of sleep disorders with melatonin. | Q48852405 | ||
| An investigation on sleep disturbance of autistic children. | Q49091055 | ||
| Evidence of pineal endocrine hypofunction in autistic children | Q49253980 | ||
| Are there "autistic-like" features in congenitally blind children? | Q50302275 | ||
| More on melatonin | Q50302331 | ||
| Brief report: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism | Q50303476 | ||
| Autism and hypomelanosis of Ito in twins | Q50304854 | ||
| Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder | Q50307004 | ||
| Brief report: Recognition of autism spectrum disorder before one year of age: a retrospective study based on home videotapes | Q50312874 | ||
| Usefulness of melatonin for developmental sleep and emotional/behavior disorders--studies of melatonin trial on 50 patients with developmental disorders | Q50313606 | ||
| Pharmacokinetics of melatonin in human sexual maturation. | Q51033617 | ||
| Melatonin reduces X-ray radiation-induced lung injury in mice by modulating oxidative stress and cytokine expression. | Q53358016 | ||
| Very early signs of autism reported by parents include many concerns not specific to autism criteria | Q58171415 | ||
| Adipokines and Adipocyte Function in Clock Mutant Mice That Retain Melatonin Rhythmicity | Q59709675 | ||
| Twenty-four hour urinary excretion of 6-hydroxymelatonin sulfate in Down syndrome subjects | Q71121577 | ||
| The cross-modal coordination of interpersonal timing: six-week-olds infants' gaze with adults' vocal behavior | Q77850623 | ||
| Behavioral speed contagion: automatic modulation of movement timing by observation of body movements | Q80571183 | ||
| Circadian modulation of human erythrocyte plasma membrane redox system by melatonin | Q84073737 | ||
| Elevated daytime melatonin concentrations in autism: A pilot study | Q88998440 | ||
| Melatonin action in the pituitary: neuroendocrine synchronizer and developmental modulator? | Q35080117 | ||
| Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters | Q35139570 | ||
| Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment | Q35947025 | ||
| Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade? | Q35947030 | ||
| Oscillation of clock and clock controlled genes induced by serum shock in human breast epithelial and breast cancer cells: regulation by melatonin | Q36251714 | ||
| Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial | Q36372805 | ||
| Melatonin and human rhythms | Q36474457 | ||
| Therapeutic application of melatonin in mild cognitive impairment. | Q36576496 | ||
| Altered circadian expression of cytokines and cytolytic factors in splenic natural killer cells of Per1(-/-) mutant mice | Q36679671 | ||
| Parent-infant synchrony and the construction of shared timing; physiological precursors, developmental outcomes, and risk conditions | Q36758633 | ||
| The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. | Q37161368 | ||
| The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders | Q37217240 | ||
| Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. | Q37332233 | ||
| Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): a randomized controlled trial | Q37369290 | ||
| Circadian rhythms and sleep in children with autism | Q37644989 | ||
| Getting answers from babies about autism | Q37675414 | ||
| Clinical uses of melatonin: evaluation of human trials | Q37737750 | ||
| At the crossroads between psychoanalysis and neuroscience: The importance of subjectivity | Q37785271 | ||
| Melatonin as the most effective organizer of the rhythm of protein synthesis in hepatocytes in vitro and in vivo | Q37808501 | ||
| Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussion. | Q37851731 | ||
| Melatonin as a central molecule connecting neural development and calcium signaling | Q37861604 | ||
| Infant rhythms versus parental time: promoting parent-infant synchrony | Q37904031 | ||
| Melatonin: both master clock output and internal time-giver in the circadian clocks network | Q37931490 | ||
| Sleep in children with autism spectrum disorder | Q38042257 | ||
| Melatonin and clock genes expression in the cardiovascular system | Q38070615 | ||
| Effect of chronic melatonin administration on several physiological parameters from old Wistar rats and SAMP8 mice. | Q38079647 | ||
| Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism | Q39115297 | ||
| The pineal gland: a neurochemical transducer | Q39874149 | ||
| Concepts of autism: a review of research | Q39980651 | ||
| Melatonin. A Mammalian Pineal Hormone* | Q40126035 | ||
| Use of melatonin in the treatment of paediatric sleep disorders | Q41301692 | ||
| Melatonin site and mechanism of action: single or multiple? | Q41649636 | ||
| Melatonin: a sleep-promoting hormone. | Q41672320 | ||
| Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin | Q42166598 | ||
| Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome | Q42519840 | ||
| Melatonin: a panacea for desperate parents? (Hype or truth). | Q42699214 | ||
| Loss of response to melatonin treatment is associated with slow melatonin metabolism. | Q43006480 | ||
| Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. | Q43202668 | ||
| Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals | Q43239157 | ||
| Daily infusion of melatonin entrains circadian activity rhythms in the diurnal rodent Arvicanthis ansorgei | Q44016871 | ||
| Entrainment of circadian activity rhythms in rats to melatonin administered at T cycles different from 24 hours | Q44037246 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autism spectrum disorder | Q1436063 |
| melatonin | Q180912 | ||
| heterocyclic compound | Q193430 | ||
| catalysis | Q82264 | ||
| organic chemistry | Q11351 | ||
| pervasive developmental disorder | Q6691991 | ||
| hormone | Q11364 | ||
| autism | Q38404 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 20508-42 | |
| P577 | publication date | 2013-10-14 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives | |
| P478 | volume | 14 |
| Q30577543 | A novel automated behavioral test battery assessing cognitive rigidity in two genetic mouse models of autism |
| Q99548991 | Analyzing the Potential Biological Determinants of Autism Spectrum Disorder: From Neuroinflammation to the Kynurenine Pathway |
| Q28080719 | Autism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectives |
| Q38246388 | Autism biomarkers: challenges, pitfalls and possibilities |
| Q59326917 | Brain hyperserotonemia causes autism-relevant social deficits in mice |
| Q38939664 | Clock Genes and Altered Sleep-Wake Rhythms: Their Role in the Development of Psychiatric Disorders. |
| Q28082433 | Complementary and Alternative Therapies for Autism Spectrum Disorder |
| Q38271292 | Current Phase II investigational therapies for insomnia |
| Q33997473 | Gene × Environment interactions in autism spectrum disorders: role of epigenetic mechanisms. |
| Q47653834 | Immune-pineal axis - acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes. |
| Q92711524 | Investigating Potential Biomarkers in Autism Spectrum Disorder |
| Q50418448 | Low maternal melatonin level increases autism spectrum disorder risk in children |
| Q50304298 | Making progress in autism drug discovery |
| Q47739841 | Melatonin and circadian rhythms in autism: Case report |
| Q39061446 | Melatonin: pharmacology, functions and therapeutic benefits |
| Q59791335 | Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models |
| Q61798771 | Morning Plasma Melatonin Differences in Autism: Beyond the Impact of Pineal Gland Volume |
| Q47557441 | New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation |
| Q47936966 | Nocturnal light pollution and underexposure to daytime sunlight: Complementary mechanisms of circadian disruption and related diseases |
| Q30235312 | Role of Genetics in the Etiology of Autistic Spectrum Disorder: Towards a Hierarchical Diagnostic Strategy |
| Q38684197 | Sleep in Children with Autism Spectrum Disorder. |
| Q88935101 | Sleep in Infants and Children with Prenatal Alcohol Exposure |
| Q65000720 | Systematic Review of Sleep Disturbances and Circadian Sleep Desynchronization in Autism Spectrum Disorder: Toward an Integrative Model of a Self-Reinforcing Loop. |
| Q90396141 | The Neurochemistry of Autism |
| Q102075254 | The influence of circadian rhythms and aerobic glycolysis in autism spectrum disorder |
| Q30436298 | The melatonin receptor agonist ramelteon effectively treats insomnia and behavioral symptoms in autistic disorder |
| Q34739720 | The relationship between sleep and behavior in autism spectrum disorder (ASD): a review |
| Q64235901 | Updated View on the Relation of the Pineal Gland to Autism Spectrum Disorders |
Search more.